We are using cookies to implement functions like login, shopping cart or language selection for this website. Furthermore we use Google Analytics to create anonymized statistical reports of the usage which creates Cookies too. You will find more information in our privacy policy.
OK, I agree I do not want Google Analytics-Cookies
Quintessence International



Forgotten password?


Quintessence Int 47 (2016), No. 7     22. June 2016
Quintessence Int 47 (2016), No. 7  (22.06.2016)

Page 571-580, doi:10.3290/j.qi.a36095, PubMed:27175451

Comparison between biodentine and formocresol for pulpotomy of primary teeth: A randomized clinical trial
El Meligy, Omar Abd El Sadek / Allazzam, Sulaiman / Alamoudi, Najlaa Mohd
Objective: To assess and compare the clinical and radiographic success rates of biodentine and formocresol for pulpotomy in human primary teeth.
Method and Materials: A randomized, split-mouth, double-blind, controlled clinical trial was carried out in 37 healthy 4- to 8-year-old children with 56 pairs (112 teeth) of contralateral primary molars indicated for pulpotomy. Matched teeth in each pair were randomized to undergo either biodentine (n = 56 teeth) or formocresol (n = 56 teeth) pulpotomy. In both groups, the teeth were restored with stainless steel crowns. The teeth were evaluated clinically and radiographically at 3 and 6 months by two blinded, standardized, and calibrated examiners. The data were analyzed using chi-square and McNemar tests with a P value of < .05 considered significant.
Results: At both the 3- and 6-month follow-ups, all the 37 children with 112 treated teeth were evaluated. Clinical and radiographic success was similar for biodentine (100%) and formocresol (100%), without any statistically significant difference (P = 1). Pulp canal obliteration was radiographically observed in 10/56 (17.9%) and 7/56 (12.5%) cases in the biodentine and formocresol groups, respectively.
Conclusion: Both pulpotomy techniques showed favorable clinical and radiographic outcomes at 3 and 6 months posttreatment without any significant difference. Hence, biodentine has the potential to become a substitute for formocresol in primary molar pulpotomies.

Keywords: biodentine, formocresol, primary molars, pulpotomy